Clover Health InvestmentsCLOV
CLOV
About: Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
Employees: 570
0
Funds holding %
of 7,429 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
112% more call options, than puts
Call options by funds: $13.5M | Put options by funds: $6.36M
86% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 36
9.06% more ownership
Funds ownership: 25.29% [Q1] → 34.35% (+9.06%) [Q2]
5% more capital invested
Capital invested by funds: $380M [Q1] → $399M (+$19.2M) [Q2]
2% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 49
4% less funds holding
Funds holding: 199 [Q1] → 192 (-7) [Q2]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$3
13%
upside
Avg. target
$3.55
34%
upside
High target
$4.10
55%
upside
2 analyst ratings
1 positive
50%
1 neutral
50%
0 negative
0%
Canaccord Genuity Richard Close | 55%upside $4.10 | Buy Maintained | 7 Aug 2025 |
UBS Jonathan Yong | 13%upside $3 | Neutral Maintained | 6 Aug 2025 |
Financial journalist opinion
Based on 12 articles about CLOV published over the past 30 days
Neutral
Zacks Investment Research
4 days ago
Bears are Losing Control Over Clover Health Investments (CLOV), Here's Why It's a 'Buy' Now
Clover Health Investments (CLOV) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Positive
Seeking Alpha
2 weeks ago
Clover Health: Short-Term Pain Hides Its Long-Term Profitability Potential
While Clover Health's Q2 earnings showed continued member and revenue growth, it dropped 30% since then due to higher medical costs that impacted all MA plan providers. Clover Health still maintains industry-leading medical cost ratios despite the short-term cost headwinds, a testament to its tech-based business model. The implementation of negotiated drug prices in 2026, combined with the 5.06% MA payout increase by CMS and the 5% quality bonus, could help Clover offset the higher medical costs.
Negative
Zacks Investment Research
2 weeks ago
CLOV Q2 Earnings In Line, Stock Falls on Raised Insurance BER View
Clover Health's Q2 revenues rise 34%, but raised Insurance BER guidance and margin pressures cause shares to tumble post-earnings.
Positive
The Motley Fool
2 weeks ago
Clover Health (CLOV) Q2 Sales Up 34%
Clover Health (CLOV) Q2 Sales Up 34%
Neutral
Seeking Alpha
2 weeks ago
Clover Health Investments, Corp. (CLOV) Q2 2025 Earnings Call Transcript
Clover Health Investments, Corp. (NASDAQ:CLOV ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Andrew Toy - Co-Founder, CEO & Director Peter J. Kuipers - Chief Financial Officer Ryan Schmidt - Corporate Participant Investor Relations Analyst - Corporate Participant Conference Call Participants John Granville Pinney - Canaccord Genuity Corp., Research Division Matthew Gregory Hewitt - Craig-Hallum Capital Group LLC, Research Division Operator Ladies and gentlemen, good afternoon, and welcome to the Clover Health Second Quarter 2025 Earnings Conference Call.
Positive
Zacks Investment Research
2 weeks ago
Clover Health Investments, Corp. (CLOV) Q2 Earnings Meet Estimates
Clover Health Investments, Corp. (CLOV) came out with quarterly earnings of $0.03 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.01 per share a year ago.
Neutral
GlobeNewsWire
2 weeks ago
Clover Health Reports Second Quarter 2025 Results; Delivering Strong Sustainable Growth
Second quarter 2025 Medicare Advantage membership of 106,323, up 32% year-over-year Second quarter 2025 Total revenues of $478 million, up 34% year-over-year Second quarter 2025 profitability metrics with GAAP Net loss of $11 million, Adjusted EBITDA of $17 million, and Adjusted Net income of $17 million Updates Full Year 2025 Guidance: Increases Average Medicare Advantage membership to 104,000 - 108,000, representing 32% growth year-over-year at the midpoint Maintains Insurance revenue between $1.800 billion and $1.875 billion, representing 37% growth year-over-year at the midpoint Improves Adjusted SG&A to between $335 million and $345 million, representing Adjusted SG&A as a percentage of Total revenues between 18% - 19% Maintains Adjusted EBITDA profitability between $50 million and $70 million Maintains Adjusted Net income between $50 million and $70 million Expects Insurance BER now between 88.5% - 89.5% WILMINGTON, Del., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today reported financial results for the second quarter 2025.
Neutral
GlobeNewsWire
3 weeks ago
Primary Care Physician Use of Counterpart Assistant Technology Linked to Better Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease
New whitepaper shows that a relationship with a primary care physician (“PCP”) who uses Counterpart Assistant is correlated with more frequent Chronic Obstructive Pulmonary Disease (“COPD”) diagnosis, increased specialty care, and meaningful reductions in hospitalizations (15% lower) and 30-day readmissions (18% lower).
Positive
Zacks Investment Research
3 weeks ago
Clover Health Pre-Q2 Earnings Analysis: Buy, Sell or Hold the Stock?
CLOV's second-quarter results are likely to reflect strong Medicare Advantage membership growth and expansion and deeper integration of Clover Assistant.
Neutral
GlobeNewsWire
3 weeks ago
Clover Health Applauds White House and CMS' Push to “Tear Down Digital Walls,” Accelerating and Simplifying Access to Health Data for Patients and Their Clinicians
WILMINGTON, Del., July 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a physician enablement company bringing access to great healthcare to everyone on Medicare, strongly supports the White House and Centers for Medicare & Medicaid Services' (CMS) announcement calling on the healthcare industry to “tear down digital walls” and build a truly patient-centric, interoperable ecosystem.
Charts implemented using Lightweight Charts™